PXD042875 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | Bottom-up proteomics of EZH2 mutants in isogenic cells |
Description | The Enhancer of Zeste 2 Polycomb Repressive Complex 2 Subunit (EZH2) is an essential epigenetic modifier able to methylate lysine 27 on histone H3 (H3K27) to induce chromatin compaction, protein complex recruitment and ultimately transcriptional repression. Hematologic malignancies, including Diffuse Large B cell lymphoma (DLBCL) and Acute myeloid leukemia (AML) have shown a high EZH2-mutation frequency (>20%) associated with poor clinical outcomes. Particularly, two distinct oncogenic mutations, so-called gain-of-function (Y641F and A677G) and loss-of-function (H689A and F667I) are found in the catalytic domain of EZH2. In this study, a comprehensive multi-omics approach was employed to characterize downstream effects of H3K27me3 deposition driven by EZH2 mutations. Human embryonic kidney cells (HEK293T) were transfected to generate three stable EZH2 mutants: EZH2(Y641F), EZH2(A677G), and EZH2(H689A/F667I), which were validated via immunoblotting and DIA-MS-based histone profiling assay. Subsequently, constructs were analyzed under a comprehensive multi-omics approach including label-free whole-cell proteomics, acquired with a Bruker timsTOF Pro HPLC-MS/MS with Ion Mobility. Important protein interactors at nuclear level were dysregulated, such as SMYD3 (SET and MYND domain containing 3), NSD2 (nuclear receptor binding SET domain protein 2) and CHD7 (chromodomain helicase DNA binding protein 7), suggesting a cooperative network of chromatin remodelers for gene expression reprogramming. |
HostingRepository | PRIDE |
AnnounceDate | 2024-10-22 |
AnnouncementXML | Submission_2024-10-22_06:12:52.334.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | Julian Aldana |
SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: 9606; |
ModificationList | iodoacetic acid derivatized residue |
Instrument | Bruker Daltonics timsTOF series |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2023-06-11 07:00:28 | ID requested | |
1 | 2023-10-24 13:37:09 | announced | |
2 | 2023-11-14 09:11:32 | announced | 2023-11-14: Updated project metadata. |
⏵ 3 | 2024-10-22 06:12:54 | announced | 2024-10-22: Updated project metadata. |
Publication List
10.3390/ijms241411378; |
Aldana J, Gardner ML, Freitas MA, Integrative Multi-Omics Analysis of Oncogenic EZH2 Mutants: From Epigenetic Reprogramming to Molecular Signatures. Int J Mol Sci, 24(14):(2023) [pubmed] |
Keyword List
submitter keyword: lymphoma, epigenetics, leukemia, mutations,EZH2 |
Contact List
Michael A. Freitas |
contact affiliation | Cancer Biology and Genetics, Wexner Medical Center, The Ohio State University, Columbus, OH, USA |
contact email | freitas.5@osu.edu |
lab head | |
Julian Aldana |
contact affiliation | The Ohio State University |
contact email | aldanaaroca.1@osu.edu |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2023/10/PXD042875 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD042875
- Label: PRIDE project
- Name: Bottom-up proteomics of EZH2 mutants in isogenic cells